EIN: 200132719 · Tax Year 2019 · Source: IRS Form 990
| Metric | Amount |
|---|---|
| Total Revenue | $6.8M |
| Total Expenses | $6.0M |
| Net Income | $811K |
| Total Assets (End of Year) | $20.9M |
Translational Research In Oncology Us Inc reported $6.8M in total revenue for the 2019 tax year, with $6.0M in total expenses and $20.9M in net assets.
Detailed spending breakdown data is not available for Translational Research In Oncology Us Inc's 2019 filing.
This data comes from Translational Research In Oncology Us Inc's IRS Form 990 filed for the 2019 tax year. Form 990 is a public document that all tax-exempt organizations must file annually with the IRS.
The IRS Form 990 is a public document that tax-exempt organizations must file annually. It provides detailed information about an organization's finances, governance, and activities. Key sections include revenue and expenses, compensation of officers, and program accomplishments.
All data shown on this page comes directly from Translational Research In Oncology Us Inc's publicly available IRS Form 990 for the 2019 tax year. This information is provided for transparency and research purposes.